Ligand · MYU
MYU · 3,5,6,7-tetrahydroxy-2-(3,4-dihydroxyphenyl)-4H-chromen-4-one
MYU, 3,5,6,7-tetrahydroxy-2-(3,4-dihydroxyphenyl)-4H-chromen-4-one (C15 H10 O8, 318.2 g/mol), in the MolNFT structures on GenesisL1: bound in 4 records (2 PDB entries). Every binding site with its residues within 4.5 Å, the residues it…
- Component
- MYU
- Formula
- C15 H10 O8
- Class
- ligand
- Structures
- 4
- PDB entries
- 2
Binding sites
MYU in 4 structures; the first of them:
- 2O64 · Crystal structure of Pim1 with Quercetagetin · MYU A501 · binds LEU44, PHE49, VAL52, ALA65, LYS67, GLU89, ILE104, LEU120 and 8 more
- 3V3V · Structural and functional analysis of quercetagetin, a natural JNK1 inhibitor · MYU A401 · binds ILE32, SER34, VAL40, ALA53, LYS55, GLU73, ILE86, MET108 and 9 more
- 2O64 · Crystal structure of PIM1 with quercetagetin · MYU A501 · binds LEU44, PHE49, VAL52, ALA65, LYS67, GLU89, ILE104, LEU120 and 8 more
- 3V3V · Structural and functional analysis of quercetagetin, a natural JNK1 inhibitor · MYU A401 · binds ILE32, SER34, VAL40, ALA53, LYS55, GLU73, ILE86, MET108 and 9 more
Residues it binds most
LEU 4, GLU 4, ILE 4, VAL 4, ALA 4, ASP 4, LYS 4, MET 2, PHE 2, ARG 2 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.